Marker Therapeutics Inc (MRKR)
3.10
+0.15
(+5.02%)
USD |
NASDAQ |
Nov 22, 16:00
3.22
+0.12
(+3.87%)
After-Hours: 20:00
Marker Therapeutics Enterprise Value: 18.66M for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 18.66M |
| November 21, 2024 | 17.34M |
| November 20, 2024 | 19.38M |
| November 19, 2024 | 19.47M |
| November 18, 2024 | 17.15M |
| November 15, 2024 | 18.40M |
| November 14, 2024 | 22.23M |
| November 13, 2024 | 23.48M |
| November 12, 2024 | 24.20M |
| November 11, 2024 | 24.82M |
| November 08, 2024 | 27.94M |
| November 07, 2024 | 29.28M |
| November 06, 2024 | 24.55M |
| November 05, 2024 | 24.02M |
| November 04, 2024 | 22.41M |
| November 01, 2024 | 23.66M |
| October 31, 2024 | 27.14M |
| October 30, 2024 | 27.32M |
| October 29, 2024 | 27.50M |
| October 28, 2024 | 29.55M |
| October 25, 2024 | 29.59M |
| October 24, 2024 | 26.78M |
| October 23, 2024 | 31.25M |
| October 22, 2024 | 31.51M |
| October 21, 2024 | 24.02M |
| Date | Value |
|---|---|
| October 18, 2024 | 22.41M |
| October 17, 2024 | 20.00M |
| October 16, 2024 | 22.41M |
| October 15, 2024 | 20.18M |
| October 14, 2024 | 21.25M |
| October 11, 2024 | 15.18M |
| October 10, 2024 | 13.22M |
| October 09, 2024 | 14.38M |
| October 08, 2024 | 14.47M |
| October 07, 2024 | 15.81M |
| October 04, 2024 | 15.99M |
| October 03, 2024 | 14.68M |
| October 02, 2024 | 14.11M |
| October 01, 2024 | 15.18M |
| September 30, 2024 | 16.16M |
| September 27, 2024 | 18.08M |
| September 26, 2024 | 16.74M |
| September 25, 2024 | 15.22M |
| September 24, 2024 | 15.93M |
| September 23, 2024 | 15.40M |
| September 20, 2024 | 18.43M |
| September 19, 2024 | 18.34M |
| September 18, 2024 | 16.92M |
| September 17, 2024 | 17.09M |
| September 16, 2024 | 17.90M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-11.48M
Minimum
Feb 23 2022
231.02M
Maximum
Jun 14 2021
44.18M
Average
28.73M
Median
Enterprise Value Benchmarks
| AIM ImmunoTech Inc | 8.915M |
| Perspective Therapeutics Inc | -31.63M |
| Protalix BioTherapeutics Inc | 97.03M |
| Electromed Inc | 238.10M |
| Armata Pharmaceuticals Inc | 171.67M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.308M |
| Total Expenses (Quarterly) | 2.400M |
| EPS Diluted (Quarterly) | -0.26 |
| Earnings Yield | -35.48% |
| Normalized Earnings Yield | -164.97 |